2009
DOI: 10.1111/j.1365-2265.2008.03426.x
|View full text |Cite
|
Sign up to set email alerts
|

Placental production and maternal serum and urine levels of inhibin A and activin A are modified by antihypertensive therapy in hypertensive disorders of pregnancy

Abstract: Our data indicate that antihypertensive therapy with alpha-methyldopa may have an effect on the synthesis and/or release of placental proteins in pregnancies complicated by PE and that this effect may be independent of its known antihypertensive action.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

0
10
0

Year Published

2009
2009
2015
2015

Publication Types

Select...
7

Relationship

2
5

Authors

Journals

citations
Cited by 11 publications
(10 citation statements)
references
References 62 publications
0
10
0
Order By: Relevance
“…Overall, the main benefit of antihypertensive treatment in these women is an improvement in maternal outcomes, in particular a halving of the risk of developing severe hypertension (relative risk 0.50; 95% CI, 0.41–0.61). We have previously shown in the same population of women that α‐methyldopa therapy is associated with a fall in maternal serum and placental levels of soluble fms‐like tyrosine kinase 1, soluble endoglin39, inhibin A, activin A40 and in arterial stiffness as measured by pulse‐wave analysis41, in women presenting with pre‐eclampsia.…”
Section: Discussionmentioning
confidence: 94%
“…Overall, the main benefit of antihypertensive treatment in these women is an improvement in maternal outcomes, in particular a halving of the risk of developing severe hypertension (relative risk 0.50; 95% CI, 0.41–0.61). We have previously shown in the same population of women that α‐methyldopa therapy is associated with a fall in maternal serum and placental levels of soluble fms‐like tyrosine kinase 1, soluble endoglin39, inhibin A, activin A40 and in arterial stiffness as measured by pulse‐wave analysis41, in women presenting with pre‐eclampsia.…”
Section: Discussionmentioning
confidence: 94%
“…All women were non-smokers, with normal body mass index (20)(21)(22)(23)(24)(25)(26)(27)(28)(29)(30), not on any medication, and had regular menstrual cycles. The date of the last menstrual period (LMP) was used to calculate the gestational age, and women with a history of recurrent miscarriages or who did not know their LMP were excluded from the study.…”
Section: Methodsmentioning
confidence: 99%
“…28,29 Briefly, the homogenization buffer was made up of a solution of Complete Protease Inhibitor Cocktail ™ tablets (Roche Diagnostics, Mannheim, Germany) dissolved in 2 mL of redistilled water, then 48 mL of fresh 100 mM phosphate buffer (PBS) were added, as per manufacturer's instructions. 28,29 Briefly, the homogenization buffer was made up of a solution of Complete Protease Inhibitor Cocktail ™ tablets (Roche Diagnostics, Mannheim, Germany) dissolved in 2 mL of redistilled water, then 48 mL of fresh 100 mM phosphate buffer (PBS) were added, as per manufacturer's instructions.…”
Section: Preparation Of Placental Villous Tissue Extractsmentioning
confidence: 99%
“…Cultured villous explants were homogenized for cytokine analysis. Homogenization of villous tissue was carried out as previously described by our group [20]. All cytokines/receptors concentrations in villous explants homogenates and culture-conditioned medium were normalized against weight of tissue/well as pg/gram villous tissue.…”
Section: Methodsmentioning
confidence: 99%